About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in San Antonio | 43 Studies

Clinical Trials COVID-19San Antonio

COVID-19 Clinical Trials in San Antonio

Find 43 clinical trials for covid-19 near San Antonio, Texas. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 43 trials

CompletedRECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID SymptomsThis platform protocol is designed to be flexible so that it is suitable for a wide range of settings within health care systems, for remote settings, and in community settings…NCT05965752·Phoenix, Arizona and 23 others CompletedAdaptive COVID-19 Treatment Trial 3 (ACTT-3)ACTT-3 will evaluate the combination of interferon beta-1a and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized.NCT04492475·Birmingham, Alabama and 63 others

COVID-19 Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSafety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2Study of the safety and immunogenicity of 20vPnC and a booster dose of BNT162b2 administered at the same visit or each vaccine given aloneNCT04887948·Anaheim, California and 26 others

CompletedUnderstanding the Long-term Impact of COVID-19 in Adults (RECOVER)This is a combined retrospective and prospective, longitudinal, observational meta-cohort of individuals who will enter the cohort with and without SARS-CoV-2 infection and at…NCT05172024·Birmingham, Alabama and 85 others

RecruitingModifying Adiposity Through Behavioral Strategies to Improve COVID-19 RehabilitationThe research in this VA Merit will examine the effects of obesity and Post-COVID Conditions (PCC) on physical functioning, health-related quality of life, and adipose tissue…NCT05880108·Baltimore, Maryland and 1 other

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05890586·Gilbert, Arizona and 90 others

Active not recruitingA Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for…NCT07266558·Birmingham, Alabama and 149 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT06042855·Chandler, Arizona and 109 others

Active not recruitingA Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of AgeThis study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine…NCT07300839·Anniston, Alabama and 195 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05894538·Gilbert, Arizona and 92 others

TerminatedLYT-100 in Post-acute COVID-19 Respiratory DiseaseThis study is being conducted in two parts, A and B.NCT04652518·Birmingham, Alabama and 30 others

CompletedA Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy AdultsThe purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a single shot is safe and can help produce antibodies…NCT06237049·Lake Forest, California and 29 others

CompletedA Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-1283.222 versus mRNA-1273.222…NCT05815498·Huntsville, Alabama and 229 others

CompletedRegistry of Sustained Immunity to COVID-19 Among ESKD PatientsThis is a multi-center, prospective registry study of subjects undergoing hemodialysis for treatment of end-stage renal disease in a DaVita center.NCT04495764·Victorville, California and 11 others

TerminatedStudy of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and OlderThe purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent) as part of primary series…NCT04904549·Birmingham, Alabama and 85 others

TerminatedCPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 PatientsThis is a phase 3, randomized, placebo controlled, double-blind, multicenter, stratified study of CPI-006 plus standard of care (SOC) versus placebo plus SOC in mild to moderately…NCT04734873·Chula Vista, California and 90 others

CompletedTo Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.Substudy A: The study will evaluate the safety, tolerability, and efficacy of a booster dose of BNT162b2 when administered to participants having previously received 2 doses of…NCT04955626·Athens, Alabama and 153 others

CompletedAdaptive COVID-19 Treatment Trial 2 (ACTT-2)ACTT-2 will evaluate the combination of baricitinib and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized.NCT04401579·Birmingham, Alabama and 70 others

CompletedEvaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia PatientsThis double blind, randomized study is aiming to evaluate the efficacy of three doses (1gr/day) of methylpredisolone added to standard therapy in patients, with documented…NCT04673162·Sanremo, Imperia and 19 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05894577·Chandler, Arizona and 108 others

Page 1 of 3Next

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia